LYNX1 CAPITAL MANAGEMENT LP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | GHRS | 8.60M | $104.31M |
 | TCRX | 7.86M | $14.30M |
 | CCCC | 7.10M | $15.76M |
 | CGEM | 5.77M | $34.19M |
 | STOK | 5.40M | $109.88M |
 | MRUS | 1.53M | $144.44M |
 | ADCT | 1.33M | $5.30M |
 | IBIO | 1.06M | $874.07K |
 | DTIL | 1.04M | $5.76M |
 | PTGX | 700K | $46.50M |
 | PASG | 624K | $5.01M |
 | ALLO | 546K | $677.19K |
 | DNLI | 262K | $3.80M |
 | DSGN | 66K | $496.63K |
GH Research PLC
GHRS
Shares Held
8.60M
Value
$104.31M
TScan Therapeutics, Inc.
TCRX
Shares Held
7.86M
Value
$14.30M
C4 Therapeutics, Inc.
CCCC
Shares Held
7.10M
Value
$15.76M
Cullinan Therapeutics, Inc.
CGEM
Shares Held
5.77M
Value
$34.19M
Stoke Therapeutics, Inc.
STOK
Shares Held
5.40M
Value
$109.88M
Merus N.V.
MRUS
Shares Held
1.53M
Value
$144.44M
ADC Therapeutics S.A.
ADCT
Shares Held
1.33M
Value
$5.30M
iBio, Inc.
IBIO
Shares Held
1.06M
Value
$874.07K
Precision BioSciences, Inc.
DTIL
Shares Held
1.04M
Value
$5.76M
Protagonist Therapeutics, Inc.
PTGX
Shares Held
700K
Value
$46.50M
Passage Bio, Inc.
PASG
Shares Held
624K
Value
$5.01M
Allogene Therapeutics, Inc.
ALLO
Shares Held
546K
Value
$677.19K
Denali Therapeutics Inc.
DNLI
Shares Held
262K
Value
$3.80M
Design Therapeutics, Inc.
DSGN
Shares Held
66K
Value
$496.63K